Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years' Time

Transplant Proc. 2020 Dec;52(10):3186-3191. doi: 10.1016/j.transproceed.2020.03.023. Epub 2020 Jul 6.

Abstract

Introduction: In this study,we investigated the presence of cytomegalovirus (CMV) infection in kidney transplanted children and its effect on kidney dysfunction.

Material and methods: One hundred thirty-five pediatric renal transplant patients were included in this study. The presence of CMV infection, CMV risk status, and other clinical features of the patients were evaluated retrospectively.

Results: Fifty-three percent of all patients and 68.8% of patients with CMV were male. The mean age was 12 years in all patients and CMV groups. According to the CMV risk classification, 40.9% of the patients with CMV infection/disease were in the high-risk group (CMV D+R-). In CMV risk groups, the presence of CMV infection/disease was similar. Cold ischemia time, male sex (patients and donors), deceased donor, higher HLA-mismatches, and cumulative antithymocyte globulin dose were found as risk factors for CMV infection/disease. Acute rejection/graft failure was observed in 27% of all patients. CMV infection has no effect on rejection/graft failure and survival.

Discussion: The frequency and risk factors of CMV in renal transplant children in our study were consistent with the literature.

Conclusions: CMV infection was found in one-fifth of our patients and the majority (71.9%) of them developed infection in the first 6 months. In one-third of our patients acute rejection/graft failure was observed. There was no effect of CMV infection on rejection/graft failure and survival in pediatric patients with proper and effective treatment.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Child
  • Cytomegalovirus / immunology
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / epidemiology*
  • Cytomegalovirus Infections / immunology*
  • Female
  • Graft Rejection / virology
  • Humans
  • Immunocompromised Host*
  • Kidney Transplantation*
  • Male
  • Postoperative Complications / immunology
  • Postoperative Complications / virology*
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome

Substances

  • Antiviral Agents